EISAI CO
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public
- Established
- 1941-12-06
- Employees
- 11K
- Market Cap
- $12B
- Website
- http://www.eisai.co.jp
A Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2007-03-08
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 373
- Registration Number
- NCT00444613
Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures
- First Posted Date
- 2006-12-27
- Last Posted Date
- 2014-07-11
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT00416195
- Locations
- 🇱🇻
Hospital Gailezers, Riga, Latvia
🇱🇻P. Stradina Clinical University Hospital, Riga, Latvia
Phase I Clinical Study of E7389
- First Posted Date
- 2006-05-17
- Last Posted Date
- 2012-03-08
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT00326950
A Comparative Study on the Efficacy and Safety of E3810 in Patients With Non-erosive Gastroesophageal Reflux Disease
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2011-07-18
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 288
- Registration Number
- NCT00165646
A Study of E7070 in Patients With Gastric Cancer
Phase 1
Terminated
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2014-01-23
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT00165594
Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth Spasmodic Torticollis
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2014-03-10
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 133
- Registration Number
- NCT00165776
Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2014-07-22
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 240
- Registration Number
- NCT00165698
- Locations
- 🇨🇳
Beijing Hospital, Beijing, China
🇨🇳Hua Dong Hospital, Shanghai, China
🇨🇳Chinese PLA General Hospital, Beijing, China
The Role of Methycobalamin in Early Dementia Patients With Vitamin B12 Deficiency and Hyperhomocysteinaemia.
Phase 4
Completed
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2019-02-19
- Lead Sponsor
- Eisai Co., Ltd.
- Registration Number
- NCT00165711
- Locations
- 🇨🇳
Chinese University of Hong Kong, Hong Kong, Hong Kong, China
A Double-blind, Comparative Study in Patients With Gastric Ulcer to Evaluate the Efficacy of Combination Use of E0671 and Rabeprazole Sodium
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-08-02
- Last Posted Date
- 2018-10-29
- Lead Sponsor
- Eisai Co., Ltd.
- Target Recruit Count
- 520
- Registration Number
- NCT00125736
© Copyright 2024. All Rights Reserved by MedPath